0.30Open0.30Pre Close0 Volume350 Open Interest17.50Strike Price0.00Turnover78.74%IV19.06%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry0.30Extrinsic Value100Contract SizeAmericanOptions Type0.2155Delta0.1103Gamma49.83Leverage Ratio-0.0213Theta0.0015Rho10.74Eff Leverage0.0099Vega
RxSight Stock Discussion
RxSight Cuts 2025 Revenue Target by $25M Despite Strong Lens Sales Growth
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S (ASND.US)$
$Vaxcyte (PCVX.US)$
$Legend Biotech (LEGN.US)$
$Janux Therapeutics (JANX.US)$
$Aerovate (AVTE.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Evolent Health (EVH.US)$
$NewAmsterdam Pharma (NAMS.US)$
$RxSight (RXST.US)$
$TYRA BIOSCIENCES, INC. (TYRA.US)$
$Edgewise Therapeutics (EWTX.US)$
$4D Molecular Therapeutics (FDMT.US)$
$Biogen (BIIB.US)$
$PepGen (PEPG.US)$